trial

VR Therapy for Psychosis Negative Symptoms (V-NeST)

NCTId NCT03995420
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 30 (estimated)
Sponsored by Institute of Psychiatry, London
Primary completion 2021-03-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-10-15
Primary completion
2021-03-30
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Virtual Reality Therapy (V-NeST)

Sponsors

Institute of Psychiatry, LondonLead Sponsor

Sites

1 total
London, United Kingdom

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2021-03-30
Status
UNKNOWN
relationships
The graph out of here
drug
Virtual Reality Therapy (V-NeST)
drug
lead_sponsor
Institute of Psychiatry, London
company
indication
Schizophrenia
indication
Psychosis
indication
Schizophrenia
indication